2,119 results on '"Lohse, Ansgar"'
Search Results
2. Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy
3. Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial
4. Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confounding
5. „Hühnerbrühe bei Durchfall ist Folklore!“
6. List of Contributors
7. Autoimmune Hepatitis
8. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
9. Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
10. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation
11. Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
12. Autoimmune Hepatitis: Von Autoantikörpern bis Zirrhose
13. Perioperative management of pancreatic exocrine insufficiency–evidence-based proposal for a paradigm shift in pancreatic surgery
14. Preoperative TIPS and in-hospital mortality in patients with cirrhosis undergoing surgery
15. IFNγ and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in Mice
16. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
17. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
18. Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation
19. Improving quality of life in patients with rare autoimmune liver diseases by structured peer-delivered support (Q.RARE.LI): study protocol for a transnational effectiveness-implementation hybrid trial
20. Einführung 'Symposium Infektionen und Gesellschaft – was wir gelernt haben'
21. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
22. Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 – A retrospective single-center cohort study
23. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
24. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis
25. Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases
26. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
27. Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing Cholangitis
28. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
29. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
30. Magen/Darm- und Lebererkrankungen
31. Wie entwickeln wir Impfstoffe, Impfstrategien und Therapien gegen Infektionskrankheiten für die Zukunft? : Podiumsdiskussion
32. Hepatische Granulome – eine diagnostische Herausforderung
33. B cells in autoimmune hepatitis: bystanders or central players?
34. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis
35. Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
36. High risk of complications and acute-on-chronic liver failure in cirrhosis patients with acute pancreatitis
37. Disturbed lipid and amino acid metabolisms in COVID-19 patients
38. Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol.
39. Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER).
40. Tolerance and autoimmunity in the liver
41. Magen-Darm-Mittel und Lebertherapeutika
42. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
43. Mit Verstand und Bauchgefühl -Viszeralmedizin 2023
44. Molecular consequences of SARS-CoV-2 liver tropism
45. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial
46. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients
47. OS-066-YI Polyreactive immunoglobulin G is elevated in autoimmune hepatitis and drug-induced autoimmune-like hepatitis compared to self-limiting drug-induced liver injury
48. THU-534-YI Circulating matricellular fibrosis markers TSP2, IGFBP7, TSP4 and M2-macrophage marker CD163 as predictors of fibrosis and outcome in people with primary sclerosing cholangitis
49. GS-007 Prospective validation of the prognostic value of liver stiffness assessed by Fibroscan in primary sclerosing cholangitis: final results of the FICUS study
50. THU-167 Diagnostic and therapeutic trends in primary biliary cholangitis: insights from the european reference network registry (R-LIVER)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.